
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Operativer Cashflow 2011-2026 | VIVO
Operativer Cashflow Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.4 M | 66.9 M | 48 M | 36.2 M | 34.8 M | 41.4 M | 37.2 M | - | - | 44.4 M | 42.4 M | 22.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 82.4 M | 22.5 M | 45.6 M |
Operativer Cashflow Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.35 M | - | - | - | 35.6 M | - | 41.5 M | - | 25.1 M | 31.7 M | 15.7 M | 25.1 M | 5.29 M | 28.5 M | 21.1 M | 5.29 M | 9.49 M | 23.6 M | 13.8 M | 9.41 M | 5.17 M | 32.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.34 M | - | - | - | 16 M | 31.9 M | 18.9 M | 16 M | 12.5 M | 16.6 M | 10.3 M | 12.5 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.5 M | -2.35 M | 18.1 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 121.87 | 3.06 % | $ 37 B | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.67 | -8.13 % | $ 222 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 21.42 | -4.46 % | $ 1.14 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.56 | 6.85 % | $ 2.08 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 25.05 | 2.0 % | $ 696 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 183.88 | 3.92 % | $ 9.11 B | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 194.75 | 0.5 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 5.08 | 1.6 % | $ 470 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.35 | 2.33 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.51 | 2.92 % | $ 2.06 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 520.6 | 0.96 % | $ 15 B | ||
|
Illumina
ILMN
|
837 M | $ 134.5 | 1.34 % | $ 21.4 B | ||
|
Precipio
PRPO
|
685 K | $ 28.3 | -2.41 % | $ 45.4 M | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 16.26 | 0.81 % | $ 492 M | ||
|
Guardant Health
GH
|
-185 M | $ 90.36 | 5.44 % | $ 11.3 B | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.77 | - | $ 282 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.91 | 2.83 % | $ 94.4 K | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.78 | 0.4 % | $ 2.68 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.18 | -0.91 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 119.68 | 3.55 % | $ 9.87 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 270.68 | 1.62 % | $ 22.5 B | ||
|
Neuronetics
STIM
|
-20.4 M | $ 1.42 | 1.43 % | $ 93.7 M | ||
|
Celcuity
CELC
|
-153 M | $ 122.46 | -2.23 % | $ 5.73 B | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 83.82 | -0.12 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 526.6 | 2.05 % | $ 199 B | ||
|
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.75 | 6.62 % | $ 61.9 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.02 | 1.86 % | $ 21.6 B | ||
|
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 6.4 | 23.79 % | $ 5.04 M |